ArticleJournal of the National Cancer Institute2026

RE: Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.

Sheng Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.